CAS 130793-28-1
:acido (2S,3R,5S)-5-(2-formamido-4-metil-pentanoyloxi)-2-esil-3-idrossi-esadecanoico
Descrizione:
La sostanza chimica con il nome "acido (2S,3R,5S)-5-(2-formamido-4-metil-pentanoyloxi)-2-esil-3-idrossi-esadecanoico" e numero CAS "130793-28-1" è un composto organico complesso caratterizzato dalla sua stereochimica specifica e dai gruppi funzionali. Presenta più centri chirali, che contribuiscono alla sua unica struttura tridimensionale e alla potenziale attività biologica. La presenza di un gruppo formamido indica che potrebbe partecipare a varie interazioni biochimiche, mentre i gruppi esile e acido esadecanoico suggeriscono caratteristiche idrofobiche che potrebbero influenzare la sua solubilità e le interazioni con le membrane. Il gruppo idrossile aumenta la sua polarità, potenzialmente influenzando la sua reattività e le interazioni con altre molecole. Questo composto potrebbe essere di interesse nella ricerca farmaceutica o biochimica a causa della sua complessità strutturale e delle potenziali applicazioni nello sviluppo di farmaci o come sonda biochimica. Le sue proprietà specifiche, come il punto di fusione, la solubilità e la reattività, richiederebbero un'indagine empirica per caratterizzare completamente il suo comportamento in vari ambienti.
Formula:C29H55NO6
InChI:InChI=1/C29H55NO6/c1-5-7-9-11-12-13-14-15-16-18-24(36-29(35)26(30-22-31)20-23(3)4)21-27(32)25(28(33)34)19-17-10-8-6-2/h22-27,32H,5-21H2,1-4H3,(H,30,31)(H,33,34)/t24-,25-,26?,27+/m0/s1
InChI key:InChIKey=FKUNIADJSAJLGB-YIPNQBBMSA-N
SMILES:[C@H](C[C@H]([C@H](CCCCCC)C(O)=O)O)(OC([C@H](CC(C)C)NC=O)=O)CCCCCCCCCCC
Sinonimi:- L-Leucine, N-formyl-, 1-[3-carboxy-2-hydroxynonyl]dodecyl ester, [2R-[1(S*),2R*,3S*]]-
- L-Leucine, N-formyl-, (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
- N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
- Orlistat Open Ring (2S,3R,5S)-Isomer
- (2S,3R,5S)-Orlistat Open Ring Impurity
- Orlistat Open Ring Epimer impurity (Orlistat Open Ring (2S,3R,5S)-Isomer)
- orlistat open ring epimer impurity
- (Orlistat IMpurity)
- (2S,3S,5S)-5-<<(S)-2-(Formylamino)-4-methylpentanoyl>oxy>-2-hexyl-3-hydroxyhexadecanoic Acid
- Orlistat Related Compound ((2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid)
- (2S, 3R, 5S)-5-[(N-ForMyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
- Orlistat Open Ring Impurity (2S,3R,5S)-Isomer
- Orlistat open ring epimer
- (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)
- Orlistat Impurity 26
- N-ForMyl-L-leucine(1S)-1-[(2S,3S)-2-hydroxy-3-[(R)-1-phenylethylcarboMoyl)]
- nonyl]dodecyl-d3 Ester
- Orlistat Impurity
- nonyl]dodecyl Ester
- Vedi altri sinonimi
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
8 prodotti.
Orlistat Open Ring Epimer ((2S,3R,5S)-5-((formyl-L-leucyl)oxy)-2-hexyl-3-hydroxyhexadecanoic acid)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C29H55NO6Colore e forma:Yellow SolidPeso molecolare:513.40294L-Leucine, N-formyl-, (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
CAS:Formula:C29H55NO6Purezza:95%Colore e forma:SolidPeso molecolare:513.7501Orlistat Impurity 38 (Orlistat Open Ring Epimer)
CAS:Formula:C29H55NO6Colore e forma:Off-White SolidPeso molecolare:513.76(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
CAS:Formula:C29H55NO6Purezza:≥ 90%Colore e forma:White, off-white or pale yellow oil or solidPeso molecolare:513.75(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)
CAS:<p>Applications A product from thermal and hydrolytic degradation of Orlistat. Orlistat impurity.<br>References Stalder, H., et al.: Helv. Chimica Acta, 75, 1593 (1992),<br></p>Formula:C29H55NO6Colore e forma:NeatPeso molecolare:513.7501Ref: ST-EA-CP-O11005
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
CAS:Orlistat is a lipase inhibitor that is used as a weight-loss drug. It works by inhibiting the absorption of dietary fats and their subsequent conversion into triglycerides in the intestines, thereby limiting the calories absorbed. Orlistat has been shown to be effective in lymphatic and fatty acid transport, but oral bioavailability is low due to extensive first-pass metabolism. Orlistat inhibits pancreatic lipase, which may lead to reduced intestinal fat absorption and decreased systemic exposure. This drug also inhibits long-chain fatty acids from being absorbed through the intestinal wall and prevents them from being metabolized, thereby reducing lipid formulations in the blood.Formula:C29H55NO6Purezza:Min. 95%Peso molecolare:513.75 g/mol
![L-Leucine, N-formyl-, (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA000UYB.jpg&w=3840&q=75)
![(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F7W%2Fthumb%2FGM8818.jpg&w=3840&q=75)
![N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-Carboxy-2-hydroxynonyl]dodecyl Ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb%2FMM1219.15-0050.jpg&w=3840&q=75)
![(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb%2FF700590.jpg&w=3840&q=75)
![(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FIF23585.jpg&w=3840&q=75)
